Retinal Blood Flow Decreases after Treatment with Bevacizumab for Retinopathy of Prematurity

Retinal Blood Flow Decreases after Treatment with Bevacizumab for Retinopathy of Prematurity

Purpose: To compare total retinal blood flow (TRBF) rates before and after retinopathy of prematurity (ROP) treatment with intravitreal bevacizumab using laser speckle contrast imaging (LSCI). Design: A prospective cohort study. Participants: Twenty-five eyes from 14 premature infants in the neonata...

Full description

Saved in:
Bibliographic Details
Main Authors: Joyce Wang, BS, Shaiza Mansoor, BS, Jeong-Yoon Wu, BS, Christina Kilby, BS, He Forbes, MS, Ria Kapoor, BS, Sarah Ward, Jason Zhou, BS, Kristin Williams, RN, Moran Roni Levin, MD, Sripriya Sundararajan, MD, Larry Magder, PhD, Avigyan Sinha, PhD, Abhishek Rege, PhD, Janet L. Alexander, MD, MS
Format: Article
Language:English
Published: Elsevier 2025-11-01
Series:Ophthalmology Science
Subjects:
Retinopathy of prematurity
Anti-VEGF
Bevacizumab
Laser speckle contrast imaging
Plus disease
Online Access:http://www.sciencedirect.com/science/article/pii/S2666914525001551
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2666914525001551

Similar Items